EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
September 30, 2022 -0.0046
June 30, 2022 -0.026
March 31, 2022 -0.0198
December 31, 2021 -0.0154
September 30, 2021 -0.0194
June 30, 2021 -0.0104
March 31, 2021 -0.0059
December 31, 2020 -0.0291
September 30, 2020 -0.0323
June 30, 2020 -0.0345
March 31, 2020 -0.0134
December 31, 2019 -0.0134
September 30, 2019 -0.0128
June 30, 2019 -0.0063
March 31, 2019 -0.006
December 31, 2018 -0.0069
September 30, 2018 -0.0058
June 30, 2018 -0.01
March 31, 2018 -0.01
December 31, 2017 -0.01
September 30, 2017 -0.01
June 30, 2017 -0.02
March 31, 2017 -0.01
December 31, 2016 -0.01
September 30, 2016 -0.0043
Date Value
June 30, 2016 -0.01
March 31, 2016 -0.01
December 31, 2015 -0.01
September 30, 2015 -0.0044
June 30, 2015 -0.0032
March 31, 2015 -0.004
December 31, 2014 -0.0038
September 30, 2014 -0.02
June 30, 2014 -0.01
March 31, 2014 -0.004
December 31, 2013 -0.0045
September 30, 2013 -0.0029
June 30, 2013 -0.0013
March 31, 2013 -0.0003
December 31, 2012 -0.0007
September 30, 2012 -0.0006
June 30, 2012 -0.0012
March 31, 2012 0.00
December 31, 2011 0.01
September 30, 2011 0.02
June 30, 2011 0.04
March 31, 2011 0.00
December 31, 2010 -0.08
September 30, 2010 0.02
June 30, 2010 0.03

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Athersys, Inc. --
Marizyme, Inc. --
Mera Pharmaceuticals, Inc. --
Nanologix, Inc. --
PhaseRx, Inc. --